Plethora Solutions

Governance

The Directors recognise the importance of sound and effective corporate governance commensurate with the status of the Company as a company admitted to trading on AIM, as well as taking into account the interests of shareholders.

The Directors have established an audit committee, chaired by Mike Collis, to receive and review internal financial reports from management and from the Company’s auditors relating to the interim and annual accounts and to the Group's financial control and risk profile.

The Directors have also established a Remuneration and Nomination committee to determine the terms and conditions of service of directors and senior management and the allocation of options over Ordinary Shares.

The Directors will comply with Rule 21 of the AIM Rules relating to directors’ dealings as applicable to AIM companies and will take all proper and reasonable steps to ensure compliance by the Company’s applicable employees.


This Product is a proprietary development stage pharmaceutical although the European MAA has been authorized by the European Commission. Information contained on this website is provided for business development and investor relations purposes only. Patients who suffer or believe they suffer from PE should contact their physician in the first instance.